Mesoblast (MESO) Gross Margin (2016 - 2023)
Mesoblast's (MESO) quarterly Gross Margin came in at 6132.51% in Q2 2023, down 1516743.0% year-on-year from N/an in Q2 2022, and up 2.13% quarter-over-quarter from 6265.65% in Q1 2023.
Mesoblast (MESO) Gross Margin (2016 - 2023) Analysis & Trends
Mesoblast has disclosed Gross Margin across 8 years of filings, most recently posting 6132.51% for Q2 2023.
- Gross Margin for Q2 2023 came in at 6132.51%, down 1516743.0% year-over-year; the trailing twelve-month figure through Mar 2023 was 1725.77% (down 102485.0% YoY), and the FY2025 annual result was 70.17%, changed N/A from the prior year.
- Gross Margin came in at 6132.51% for Q2 2023 at Mesoblast, up from 6265.65% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 17116.73% in Q2 2021 to a low of 17383.92% in Q3 2022.
- The 5-year median for Gross Margin is 4121.36% (2019), against an average of 2528.73%.
- Across the five-year window, Gross Margin soared 1625798 bps in 2021 and sank 1516743 bps in 2023, its largest moves.
- Mesoblast's Gross Margin stood at 4284.76% in 2019, then soared by 96 bps to 187.82% in 2020, then tumbled by 3953 bps to 7612.85% in 2021, then soared by 43 bps to 4324.65% in 2022, then plunged by 42 bps to 6132.51% in 2023.
- The last three Gross Margin figures came in at 6132.51% (Q2 2023), 6265.65% (Q1 2023), and 4324.65% (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -6,132.51% |
| Mar 31, 2023 | -6,265.65% |
| Dec 31, 2022 | -4,324.65% |
| Sep 30, 2022 | -17,383.92% |
| Jun 30, 2022 | 9,034.92% |
| Mar 31, 2022 | -5,039.43% |
| Dec 31, 2021 | -7,612.85% |
| Sep 30, 2021 | -4,984.60% |
| Jun 30, 2021 | 17,116.73% |
| Mar 31, 2021 | -267.62% |
| Dec 31, 2020 | -187.82% |
| Sep 30, 2020 | -813.72% |
| Jun 30, 2020 | 858.76% |
| Mar 31, 2020 | -3,957.95% |
| Dec 31, 2019 | -4,284.76% |
| Sep 30, 2019 | -2,762.13% |
| Jun 30, 2019 | -24.45% |
| Mar 31, 2019 | -8,485.41% |
| Dec 31, 2018 | -7,347.17% |
| Sep 30, 2018 | -6,322.17% |